Literature DB >> 8911384

Long-term results of ureterosigmoidostomy in children with bladder exstrophy.

H P Koo1, L Avolio, J W Duckett.   

Abstract

PURPOSE: We evaluated long-term results of patients with bladder exstrophy who underwent ureterosigmoidostomy.
MATERIALS AND METHODS: Of 4 women and 23 men monitored at our institution 16 (59%) underwent primary diversion by ureterosigmoidostomy, while 11 (41%) underwent primary bladder closure or an ileal conduit procedure before conversion to ureterosigmoidostomy. Average followup after ureterosigmoidostomy was 17 years.
RESULTS: Significant upper urinary tract changes developed in 18% of the patients. Metabolic acidosis was well compensated in most patients but 2 had problems with urinary retention leading to hyperammonemia and acidosis. Of the 19 patients monitored with biennial colonoscopy benign polyps were removed in 4. Daytime continence was achieved in 92% of cases and nighttime continence in 58%.
CONCLUSIONS: Our experience with ureterosigmoidostomy in children with bladder exstrophy has been favorable through long-term followup. With proper imaging, metabolic surveillance, biennial colonoscopy and nonsteroidal anti-inflammatory drugs we offer ureterosigmoidostomy as a viable alternative for patients with small bladders.

Entities:  

Mesh:

Year:  1996        PMID: 8911384

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Ureterosigmoidostomy associated signet ring colon cancer presenting as hip pain.

Authors:  Rohtesh S Mehta; Peter Ennis; Joseph Whitten
Journal:  J Gastrointest Cancer       Date:  2012-03

Review 2.  Exstrophy Bladder - Reconstruction or Diversion for the Underprivileged.

Authors:  Yogesh Kumar Sarin; Virender Sekhon
Journal:  Indian J Pediatr       Date:  2017-07-18       Impact factor: 1.967

3.  Bladder exstrophy in adulthood.

Authors:  R B Nerli; G V Kamat; S S Alur; Ashish Koura; Vikram Prabha; S S Amarkhed
Journal:  Indian J Urol       Date:  2008-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.